Literature DB >> 3137899

Combined familial adenosine deaminase and purine nucleoside phosphorylase deficiencies.

A Shanon1, S Levin, F Holtzman, F Brock-Sinai, A Abu-Said.   

Abstract

We studied an Arab family in which two infants died of severe combined immunodeficiency caused by adenosine deaminase (ADA) deficiency. One infant had purine nucleoside phosphorylase (PNP) activity in the leucocytes only half that of normal. Four other infant siblings had previously died from infections before the age of 2 months. Hyperpigmented skin lesions preceded death in three cases. The healthy parents and three healthy siblings aged 4-9 years had varying degrees of both ADA and PNP deficiencies in both white and red cells. ADA deficiency was pronounced in two siblings, and mild in the third and in the parents, and PNP activity was severely deficient in one sibling, and moderately deficient in the parents and other two siblings, who were all well. Complete absence of ADA from white cells lead to the development of severe combined immunodeficiency, but even minimal residual ADA and PNP activity allowed maturation of the immune system with normal immune function.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3137899      PMCID: PMC1778999          DOI: 10.1136/adc.63.8.931

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  10 in total

Review 1.  Inherited enzyme deficiencies and immunodeficiency: adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) deficiencies.

Authors:  R Hirschhorn
Journal:  Clin Immunol Immunopathol       Date:  1986-07

2.  Red-blood-cell adenosine deaminase deficiency in a "healthy" Kung individual.

Authors:  T Jenkins
Journal:  Lancet       Date:  1973-09-29       Impact factor: 79.321

3.  Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity.

Authors:  E R Giblett; J E Anderson; F Cohen; B Pollara; H J Meuwissen
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

4.  Biochemical basis for lymphocyte dysfunction in adenosine deaminase and purine nucleoside phosphorylase deficiencies.

Authors:  D A Carson; D B Wasson; E Lakow; N Kamatani
Journal:  Adv Exp Med Biol       Date:  1984       Impact factor: 2.622

5.  Combined immunodeficiency disease associated with adenosine deaminase deficiency. Report on a workshop held in Albany, New York, October 1, 1973.

Authors:  H J Meuwissen; B Pollara; R J Pickering
Journal:  J Pediatr       Date:  1975-02       Impact factor: 4.406

6.  Pathologic findings in adenosine deaminase-deficient severe combined immunodeficiency. I. Kidney, adrenal, and chondro-osseous tissue alterations.

Authors:  H Ratech; M A Greco; G Gallo; D L Rimoin; H Kamino; R Hirschhorn
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

7.  Deficiency of adenosine deaminase not associated with severe combined immunodeficiency.

Authors:  T Jenkins; A R Rabson; G T Nurse; A B Lane
Journal:  J Pediatr       Date:  1976-11       Impact factor: 4.406

8.  Adenosine deaminase deficiency without immunodeficiency: clinical and metabolic studies.

Authors:  W Borkowsky; A A Gershon; L Shenkman; R Hirschhorn
Journal:  Pediatr Res       Date:  1980-07       Impact factor: 3.756

9.  Purine nucleoside phosphorylase deficiency associated with selective cellular immunodeficiency.

Authors:  J W Stoop; B J Zegers; G F Hendrickx; L H van Heukelom; G E Staal; P K de Bree; S K Wadman; R E Ballieux
Journal:  N Engl J Med       Date:  1977-03-24       Impact factor: 91.245

10.  Erythrocyte adenosine deaminase deficiency without immunodeficiency. Evidence for an unstable mutant enzyme.

Authors:  R Hirschhorn; V Roegner; T Jenkins; C Seaman; S Piomelli; W Borkowsky
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.